GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AI/ML Innovations Inc (FRA:42FB) » Definitions » Valuation Rank

AI/ML Innovations (FRA:42FB) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is AI/ML Innovations Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


AI/ML Innovations Valuation Rank Related Terms

Thank you for viewing the detailed overview of AI/ML Innovations's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


AI/ML Innovations (FRA:42FB) Business Description

Traded in Other Exchanges
Address
645 Fort Street, Suite 203, Victoria, BC, CAN, V8W 1G2
AI/ML Innovations Inc has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. The company has strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments.